TABLE 1.

Prophylactic trials for acute GVHD.

Study	MSC		No MSC		Risk ratio
	aGVHD events	Total participants	aGVHD events	Total participants
Ghavamzadeh et al., 2010	6	25	4	23	1.38 (0.45–4.28)
Kuzmina et al., 2012	4	39	8	38	0.49 (0.16–1.48)
Liu et al., 2011	16	27	16	28	1.04 (0.66–1.62)
Mareika et al., 2016	1	10	3	12	0.40 (0.05–3.27)
Ning et al., 2008	5	10	11	15	0.68 (0.34–1.36)
Wu et al., 2013	4	8	8	12	0.75 (0.34–1.67)

Adapted from Fisher et al. (2019).